SIMILASAN Kava-Kava cpr 80 pce

7680563910034 CH-56391 20.01.1.
SIMILASAN Kava-Kava cpr 80 pce
SIMILASAN Kava-Kava cpr 80 pce
SIMILASAN Kava-Kava cpr 80 pce
1 / 3
google

Details

Product number
5639101
CPT
-
Packaging group
80
Unit
Tablette(n)
Composition
piper methysticum ex radicis siccae D12 (HAB 4a, HAB 7) 8.33 mg, piper methysticum ex radicis siccae D15 (HAB 4a, HAB 7) 8.33 mg, piper methysticum ex radicis siccae D30 (HAB 4a, HAB 7) 8.33 mg, maydis amylum, magnesii stearas, lactosum monohydricum, pro compresso 250 mg corresp. lactosum monohydricum 241.25 mg.

Articles (1)

Similasan Kava-Kava, Tabletten
Tabletten
80
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/11/2023
Patient information leaflet
Français
28/11/2023
Patient information leaflet
Italien
28/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
8.33 MG Substance Wirkstoff (Principe actif)
(N/A)
8.33 MG Substance Wirkstoff (Principe actif)
(N/A)
8.33 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
241.25 MG Substance HBESI

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
56391
Drug name
Similasan Kava-Kava, Tabletten
Galenic form
TAB
Authorization status
Z
Dispensation category
D
First authorization
18/08/2004
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei nervösen Angstzuständen, Spannungszuständen, innerer Unruhe, Reizbarkeit, geistiger Erschöpfung und nach geistiger Überanstrengung

Packaging details

Description (FR)
SIMILASAN Kava-Kava cpr 80 pce
Description (DE)
SIMILASAN Kava-Kava Tabl 80 Stk
Market launch
18/08/2004
Narcotic (BTM)
No

Other packaging sizes